#cancer-diagnostics

[ follow ]
#liquid-biopsy #sample-preparation-technology #life-sciences-funding #cell-free-dna-extraction #biotech #ipo #ai
London startup
fromBusiness Matters
2 days ago

BIOCAPTIVA raises 1.58m to transform liquid biopsy sample preparation

BIOCAPTIVA secured £1.58 million funding to commercialize msX technology, which simplifies blood sample preparation for cancer diagnostics by using magnetic bead extraction to isolate cell-free DNA directly from whole blood.
Startup companies
fromFast Company
8 months ago

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

Caris Life Sciences' IPO reflects investor confidence in biotech amidst recent sector challenges.
[ Load more ]